Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Resources>White Papers>This White Paper
  White Papers
Scientific News
Flowering Regulation Mechanism Discovered
Monash researchers have discovered a new mechanism that enables plants to regulate their flowering in response to raised temperatures.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Nanoparticles Present Sustainable Way to Grow Food Crops
Nanoparticle technology can help reduce the need for fertilizer, creating a more sustainable way to grow crops such as mung beans.
How Scientists Use DNA to Track Disease Outbreaks
They’re the top questions on everyone’s mind when a new disease outbreak happens: where did the virus come from? When did this happen? How long has it been spreading in a particular country or group of people?
Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings
Penn Institute for Biomedical Informatics and colleagues identify "roadmap" of disease mechanisms to identify candidate drug targets.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
HIV Particles Used to Trap Intact Mammalian Protein Complexes
Belgian scientists from VIB and UGent developed Virotrap, a viral particle sorting approach for purifying protein complexes under native conditions.
Childhood Asthma Research Receives $2M
Research into the impact of a child’s upbringing and social and physical environments on the development of asthma will receive $2 million to tackle the condition that affects as many as one in three Canadians.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Scroll Up
Scroll Down

Approaches to Screening for Risk from Pharmaceuticals in Drinking Water and Prioritization for Further Evaluation
Bookmark and Share


EPA

The presence of pharmaceuticals in drinking water is not a new issue. In the 1970’s, several researchers reported the presence of clofibric acid, a breakdown product of several blood lipid regulators, and salicylic acid, a breakdown product of aspirin, in waste water. However, as analytical techniques grew more sensitive over the years, many more pharmaceuticals have been detected in ambient water, wastewater, and drinking water.

During 1999-2000, the U.S. Geological Survey carried out the first national survey of the occurrence of pharmaceuticals, hormones, and other chemicals in 139 streams from 30 states. A total of 95 contaminants were targeted, with 80 percent of the streams testing positive for one or more contaminants.

Pharmaceuticals enter water through: flushing unused medications down the toilet or sink; excreting unabsorbed medications into the sewage system; farm animals excreting veterinary drugs into fields where they run off into lakes and streams; and commercial improper disposal methods. Conventional water and wastewater treatment methods allow many pharmaceuticals to pass through unchanged, entering the environment and ultimately the drinking water.

One problem with assessing risk of pharmaceuticals in drinking water is the very large number of pharmaceuticals in use today. Information on the occurrence of pharmaceuticals in drinking water is available only for a limited number of compounds. In addition, many pharmaceuticals are biologically degraded to active metabolites that have not been evaluated. One problem with assessing risk of pharmaceuticals in drinking water is the very large number of pharmaceuticals in use today. Information on the occurrence of pharmaceuticals in drinking water is available only for a limited number of compounds. In addition, many pharmaceuticals are biologically degraded to active metabolites that have not been evaluated.

A number of different approaches have been suggested and published in the peer reviewed literature for screening and prioritizing the hazard posed by low concentrations of pharmaceuticals in drinking water. This white paper summarizes and evaluates a number of risk assessment approaches (including EPA’s current approach), that EPA is aware of, that have been described in the literature. This paper is not a comprehensive compilation of all published approaches. In addition, this paper describes EPA’s current activities and research strategy for pharmaceuticals in water.

Further Information

Related Content

Fracking Hasn't Caused Widespread Harm to Water
Assessment shows hydraulic fracturing activities have not led to widespread, systemic impacts to drinking water resources and identifies important vulnerabilities to drinking water resources.
Monday, June 08, 2015
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!